Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia
Sign Up to like & getrecommendations! Published in 2024 at "Targeted Oncology"
DOI: 10.1007/s11523-024-01039-y
Abstract: AML1/ETO fusion confers favorable prognosis in acute myeloid leukemia (AML) treated with intensive chemotherapy (IC). However, the impact of AML1/ETO fusion on the efficacy of venetoclax in the treatment of AML is unclear. The aim… read more here.
Keywords: eto fusion; efficacy venetoclax; aml; aml1 eto ... See more keywords